Selective iglur5 receptor antagonists for the treatment of...

Details Selective iglur5 receptor antagonists for the treatment of... Selective iglur5 receptor antagonists for the treatment of...

C - Chemistry, Metallurgy

07

D

C07D 401/06 (2006.01) A61K 31/472 (2006.01) A61K 31/4725 (2006.01) A61K 31/5377 (2006.01) A61P 25/06 (2006.01) C07D 413/14 (2006.01)

Patent

CA 2378613

The present invention provides a method of treating or preventing migraine comprising administering to a patient in need thereof an effective amount of a selective iGluR5 receptor antagonist. The present invention further provides novel compounds functional as selective iGluR5 receptor antagonists as well as compositions and formulations comprising said selective iGluR5 receptor antagonists.

La présente invention porte sur un procédé de traitement ou de prévention de la migraine et consiste à administrer à un patient une quantité efficace d'un antagoniste sélectif du récepteur iGluR5. La présente invention porte également sur de nouveaux composés fonctionnels utilisés comme antagonistes sélectifs du récepteur iGluR5, ainsi que sur des compositions et des formulations comprenant cet antagoniste sélectif du récepteur iGluR5.

Affiliated with

Also associated with

Rating

Selective iglur5 receptor antagonists for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Selective iglur5 receptor antagonists for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective iglur5 receptor antagonists for the treatment of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1673107